1. Design and anti-tumor activity of self-loaded nanocarriers of siRNA
   Wenzhao Han et al, 2019, Colloids and Surfaces B: Biointerfaces CrossRef
2. Co-delivery of doxorubicin and CRISPR/Cas9 or RNAi-expressing plasmid by chitosan-based nanoparticle for cancer therapy
   Qiuping Li et al, 2022, Carbohydrate Polymers CrossRef
3. Myricanol 5-fluorobenzyloxy ether regulation of survivin pathway inhibits human lung adenocarcinoma A549 cells growth in vitro
   Guan-hai Dai et al, 2020, BMC Complementary Medicine and Therapies CrossRef
4. Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells
   Rou-Hsin Wang et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
5. Genetic Modification of the Lung Directed Toward Treatment of Human Disease
   Dolan Sondhi et al, 2017, Human Gene Therapy CrossRef
6. Oncogenic activity of insulin in the development of NSCLC: What is there behind the scenes?
   Raffaella Mormile, 2018, Pulmonary Pharmacology & Therapeutics CrossRef
7. Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer
   Michał Szczyrek et al, 2022, Cells CrossRef
8. Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells
   Ya-Hui Huang et al, 2019, Cells CrossRef
9. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect
   Yudong Song et al, 2018, Biomaterials CrossRef
10. Antitumor activity of YM155, a selective survivin suppressant, in combination with cisplatin in hepatoblastoma
    YING YU et al, 2015, Oncology Reports CrossRef
11. Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA
    Junfeng Ke et al, 2022, International Journal of Molecular Sciences CrossRef
12. Survivin selective inhibitor YM155 promotes cisplatin-induced apoptosis in embryonal rhabdomyosarcoma
    TAKEHISA UENO et al, 2016, International Journal of Oncology CrossRef
13. Nanotechnology-based siRNA delivery strategies for metastatic colorectal cancer therapy
    Ana Rita Sousa et al, 2019, International Journal of Pharmaceutics CrossRef
14. Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin
    Yingqi Xu et al, 2017, Scientific Reports CrossRef
15. YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo
    ZHUO ZHANG et al, 2015, Oncology Reports CrossRef
16. Combining repurposed drugs to treat colorectal cancer
    Diana Duarte et al, 2022, Drug Discovery Today CrossRef
17. Correlation between Survivin expression and laryngeal carcinoma: A meta-analysis
    Juan Geng et al, 2017, Current Medical Science CrossRef
18. Shikonin Inhibits Non-Small-Cell Lung Cancer H1299 Cell Growth through Survivin Signaling Pathway
    Haini Wang et al, 2021, Analytical Cellular Pathology CrossRef
19. Antioxidant and antiproliferative potentials of methanol extract of Xylopia aethiopica (Dunal) A. Rich in PC-3 and LNCaP cells
    Oluwatosin Adekunle Adaramoye et al, 2017, Journal of Basic and Clinical Physiology and Pharmacology CrossRef